Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05178641 · ClinicalTrials.gov registry record · NA
Overnight Pant Study for Children With Nocturnal Enuresis
A NA study of Nocturnal Enuresis, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05178641 is a NA study of Nocturnal Enuresis that has completed, run by Procter and Gamble. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05178641, a NA study of Nocturnal Enuresis, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the in-use tolerance of an absorbent disposable underwear pant developed for children with nocturnal enuresis by assessing adverse events. In addition product performance will be assessed by the parent at home via a daily diary.
Conditions Studied
Interventions
- DEVICE Ninjamas Pyjama Pants
- OTHER Participant's Overnight Current Standard of Care
Study Locations (1)
Ohio
- North Cliff Consultants - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-01-13 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05178641
The ClinicalTrials.gov registry entry for NCT05178641 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nocturnal Enuresis appearing as the primary indexed condition, and to 2 interventions - of which Ninjamas Pyjama Pants is the first listed.
NCT05178641 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05178641 about?
NCT05178641 is a clinical study titled "Overnight Pant Study for Children With Nocturnal Enuresis". This study will evaluate the in-use tolerance of an absorbent disposable underwear pant developed for children with nocturnal enuresis by assessing adverse events. In addition product performance will be assessed by the parent at home via a daily diary.
What is the current status of trial NCT05178641?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-01-13. Estimated completion is 2022-02-28.
What conditions does trial NCT05178641 study?
This clinical trial studies the following conditions: Nocturnal Enuresis.
What interventions are being tested in trial NCT05178641?
The interventions under investigation include: Ninjamas Pyjama Pants (DEVICE), Participant's Overnight Current Standard of Care (OTHER).
Who is sponsoring clinical trial NCT05178641?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05178641 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nocturnal Enuresis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.